116 related articles for article (PubMed ID: 10488328)
21. Granulocyte-macrophage colony-stimulating factor in post-remission therapy of acute myeloid leukemia.
Sousa AB; Fernandes JP; Costa I; Ferreira G; Nunes O; Ribeiro P; Neves A; Cruz E; Aveiro F; Rodrigues AS; Bernardo M; Conduto A; Gonçalves AJ; Monteiro A; Sousa M; Soares VH; Veiga J; Gouveia J
Hematol Cell Ther; 1998 Apr; 40(2):63-6. PubMed ID: 9615248
[TBL] [Abstract][Full Text] [Related]
22. Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy.
Gupta V; Chun K; Yi QL; Minden M; Schuh A; Wells R; Brandwein J
Cancer; 2005 May; 103(10):2082-90. PubMed ID: 15830348
[TBL] [Abstract][Full Text] [Related]
23. Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach.
Mandelli F; Petti MC; Lo Coco F
Haematologica; 1998 Nov; 83(11):1015-23. PubMed ID: 9864924
[TBL] [Abstract][Full Text] [Related]
24. Treatment of childhood acute myeloid leukemia.
ter Bals E; Kaspers GJ
Expert Rev Anticancer Ther; 2005 Oct; 5(5):917-29. PubMed ID: 16221060
[TBL] [Abstract][Full Text] [Related]
25. Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia.
Lee JH; Choi SJ; Lee JH; Park JH; Kim H; Joo YD; Lee WS; Zang DY; Kim HJ; Lee KH;
Ann Hematol; 2006 Jun; 85(6):357-65. PubMed ID: 16575580
[TBL] [Abstract][Full Text] [Related]
26. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups.
Schoch C; Kern W; Schnittger S; Büchner T; Hiddemann W; Haferlach T
Haematologica; 2004 Sep; 89(9):1082-90. PubMed ID: 15377469
[TBL] [Abstract][Full Text] [Related]
27. Double intensive consolidation chemotherapy in adult acute myeloid leukemia.
Harousseau JL; Milpied N; Briere J; Desablens B; Leprise PY; Ifrah N; Gandhour B; Casassus P
Semin Hematol; 1991 Jul; 28(3 Suppl 4):80-3. PubMed ID: 1780758
[No Abstract] [Full Text] [Related]
28. [Acute myeloid leukemia in the elderly: a review].
Thomas X; Belhabri A
Bull Cancer; 2001 Feb; 88(2):143-54. PubMed ID: 11257589
[TBL] [Abstract][Full Text] [Related]
29. Remission induction therapy of untreated acute myeloid leukemia using a non-cytarabine-containing regimen of idarubicin, etoposide, and carboplatin.
Bow EJ; Gallant G; Williams GJ; Woloschuk D; Shore TB; Rubinger M; Schacter BA
Cancer; 1998 Oct; 83(7):1344-54. PubMed ID: 9762935
[TBL] [Abstract][Full Text] [Related]
30. Intensive chemotherapy with mitoxantrone administered as a single injection in patients with high-risk acute myeloid leukemia: results of the EMA 2000 trial.
Thomas X; Elhamri M; Chelghoum Y; Reman O; Arnaud P; Raffoux E; Le QH; Tavernier E; Dombret H; Michallet M
Ann Hematol; 2005 Jun; 84(6):376-82. PubMed ID: 15782343
[TBL] [Abstract][Full Text] [Related]
31. [The results of a multicenter cooperative study on treating acute myeloid leukemias in adults].
Savchenko VG; Parovichnikova EN; Kliasova GA; Isaev VG; Kulikov SM; Tikhonova LIu; Cherepanova VV; Rekhtman GB; Medvedeva NV; Kaporskaia TS
Ter Arkh; 1994; 66(7):11-7. PubMed ID: 7985120
[No Abstract] [Full Text] [Related]
32. Aggressive salvage treatment is not appropriate for the majority of elderly patients with acute myeloid leukemia relapsed from first complete remission.
Ferrara F; Morabito F; Latagliata R; Martino B; Annunziata M; Oliva E; Schiavone EM; Pollio F; Palmieri S; Gianfaldoni G; Leoni F
Haematologica; 2001 Aug; 86(8):814-20. PubMed ID: 11522537
[TBL] [Abstract][Full Text] [Related]
33. Induction of complete remission in a patient with acute myeloid leukemia refractory to high-dose chemotherapy through treatment with 5-azacytidine.
Kuendgen A; Gräf T; Zohren F; Hildebrandt B; Hünerlitürkoglu A; Gattermann N; Haas R; Kobbe G
Leuk Res; 2007 Mar; 31(3):407-9. PubMed ID: 16890286
[TBL] [Abstract][Full Text] [Related]
34. Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocol.
Oriol A; Ribera JM; Esteve J; Guàrdia R; Brunet S; Bueno J; Pedro C; Llorente A; Tormo M; Besalduch J; Sánchez JM; Batlle M; Vivancos P; Carreras E; Vilà JM; Julià A; Sierra J; Montserrat E; Feliu E;
Haematologica; 2004 Jul; 89(7):791-800. PubMed ID: 15257930
[TBL] [Abstract][Full Text] [Related]
35. Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypes.
Knipp S; Hildebrand B; Kündgen A; Giagounidis A; Kobbe G; Haas R; Aul C; Gattermann N; Germing U
Cancer; 2007 Jul; 110(2):345-52. PubMed ID: 17559141
[TBL] [Abstract][Full Text] [Related]
36. Dose-reduced induction therapy for acute leukaemias decreases both the complete remission (CR) rate and the probability of leukaemia-free survival (LFS).
Krahl R; Helbig W; Kubel M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):783-6. PubMed ID: 1713882
[TBL] [Abstract][Full Text] [Related]
37. Optimal post-remission therapy for flow-cytometry minimal residual disease positive adult patients with acute myeloid leukemia.
Buccisano F; Maurillo L; Del Poeta G; Gattei V; Amadori S; Venditti A
Haematologica; 2006 Dec; 91(12 Suppl):ELT14; author reply ELT15. PubMed ID: 17194674
[No Abstract] [Full Text] [Related]
38. Elderly acute myeloid leukemia: patients are not all the same.
Schaich M
Haematologica; 2004 Mar; 89(3):261-3. PubMed ID: 15020259
[No Abstract] [Full Text] [Related]
39. Incorporating novel treatment strategies into conventional therapy.
Estey EH
Clin Adv Hematol Oncol; 2009 Jun; 7(6):4-7. PubMed ID: 19645129
[No Abstract] [Full Text] [Related]
40. Fludarabine, cytarabine and topotecan (FLAT) as induction therapy for acute myeloid leukemia in the elderly: a preliminary report.
Leoni F; Ciolli S; Nozzoli C; Santini V; Fanci R; Rossi Ferrini P
Haematologica; 2001 Jan; 86(1):104. PubMed ID: 11146581
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
